Form 4 for OGN Organon & Co.
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001209191-23-027172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-03 | 2023-05-01 | OGN | Fiedler Susanne | Chief Commercial Off | M - OptEx | — | +2,168 | 22.8K | +11% | — |
| D | 2023-05-03 | 2023-05-01 | OGN | Fiedler Susanne | Chief Commercial Off | F - Tax | $24.63 | -1,019 | 21.8K | -4% | -$25.1K |
| D | 2023-05-03 | 2023-05-01 | OGN | Fiedler Susanne | Chief Commercial Off | M - OptEx | $0.00 | -2,168 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | M | A | 2,168 | — | 22,814 | D | — | — | (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested. |
| 2 | Common | Common Stock | 2023-05-01 | F | D | 1,019 | $24.63 | 21,795 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-05-01 | M | D | 2,168 | $0.00 | 0 | D | — · 2023-05-01 to 2023-05-01 | 2,168 Common Stock | (F1) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested. |